120 related articles for article (PubMed ID: 7964876)
1. PCR and immunoblot analyses of dystrophin in Becker muscular dystrophy.
Uchino M; Miike T; Iwashita H; Uyama E; Yoshioka K; Sugino S; Ando M
J Neurol Sci; 1994 Jul; 124(2):225-9. PubMed ID: 7964876
[TBL] [Abstract][Full Text] [Related]
2. Dystrophin immunostaining in muscles from patients with different types of muscular dystrophy: a Brazilian study.
Vainzof M; Pavanello RC; Pavanello Filho I; Passos-Bueno MR; Rapaport D; Hsi CT; Zatz M
J Neurol Sci; 1990 Sep; 98(2-3):221-33. PubMed ID: 1700808
[TBL] [Abstract][Full Text] [Related]
3. Dystrophin characterization in BMD patients: correlation of abnormal protein with clinical phenotype.
Morandi L; Mora M; Confalonieri V; Barresi R; Di Blasi C; Brugnoni R; Bernasconi P; Mantegazza R; Dworzak F; Antozzi C
J Neurol Sci; 1995 Oct; 132(2):146-55. PubMed ID: 8543940
[TBL] [Abstract][Full Text] [Related]
4. Very small dystrophin molecule in a family with a mild form of Becker dystrophy.
Morandi L; Mora M; Bernasconi P; Mantegazza R; Gebbia M; Balestrini MR; Cornelio F
Neuromuscul Disord; 1993 Jan; 3(1):65-70. PubMed ID: 8329891
[TBL] [Abstract][Full Text] [Related]
5. Delayed expression of dystrophin on regenerating muscle from two siblings with Becker muscular dystrophy.
Tachi N; Wakai S; Watanabe Y; Chiba S; Nagaoka M; Minami R
J Neurol Sci; 1992 Jul; 110(1-2):165-8. PubMed ID: 1506856
[TBL] [Abstract][Full Text] [Related]
6. Cardiac dystrophin abnormalities in Becker muscular dystrophy assessed by endomyocardial biopsy.
Maeda M; Nakao S; Miyazato H; Setoguchi M; Arima S; Higuchi I; Osame M; Taira A; Nomoto K; Toda H
Am Heart J; 1995 Apr; 129(4):702-7. PubMed ID: 7900621
[TBL] [Abstract][Full Text] [Related]
7. [Muscular dystrophies detected by immunophenotyping and genotype analysis (mRNA and DNA)].
Lukás Z; Vojtísková M; Fajkusová L; Bednarík J; Kadanka Z; Hájek J; Hermanová M; Vohánka S; Vytopil M
Cesk Patol; 2001 Nov; 37(4):137-45. PubMed ID: 11813630
[TBL] [Abstract][Full Text] [Related]
8. Quadriceps myopathy: forme fruste of Becker muscular dystrophy.
Sunohara N; Arahata K; Hoffman EP; Yamada H; Nishimiya J; Arikawa E; Kaido M; Nonaka I; Sugita H
Ann Neurol; 1990 Nov; 28(5):634-9. PubMed ID: 2260849
[TBL] [Abstract][Full Text] [Related]
9. Is dystrophin always altered in Becker muscular dystrophy patients?
Vainzof M; Passos-Bueno MR; Pavanello RC; Zatz M
J Neurol Sci; 1995 Jul; 131(1):99-104. PubMed ID: 7561956
[TBL] [Abstract][Full Text] [Related]
10. Is the maintainance of the C-terminus domain of dystrophin enough to ensure a milder Becker muscular dystrophy phenotype?
Vainzof M; Takata RI; Passos-Bueno MR; Pavanello RC; Zatz M
Hum Mol Genet; 1993 Jan; 2(1):39-42. PubMed ID: 8490621
[TBL] [Abstract][Full Text] [Related]
11. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin.
England SB; Nicholson LV; Johnson MA; Forrest SM; Love DR; Zubrzycka-Gaarn EE; Bulman DE; Harris JB; Davies KE
Nature; 1990 Jan; 343(6254):180-2. PubMed ID: 2404210
[TBL] [Abstract][Full Text] [Related]
12. Is dystrophin labelling always discontinuous in Becker muscular dystrophy?
Slater CR; Nicholson LV
J Neurol Sci; 1991 Feb; 101(2):187-92. PubMed ID: 2033404
[TBL] [Abstract][Full Text] [Related]
13. Abnormal dystrophin expression in patients with limb girdle syndromes.
Beyenburg S; Zierz S; Arahata K; Mundegar RR; Friedl W; Jerusalem F
J Neurol; 1994 Feb; 241(4):210-7. PubMed ID: 8195819
[TBL] [Abstract][Full Text] [Related]
14. Becker muscular dystrophy: demonstration of the carrier status of a female by immunoblotting and immunostaining.
Chevron MP; Tuffery S; Echenne B; Demaille J; Claustres M
Neuromuscul Disord; 1992; 2(1):47-50. PubMed ID: 1525558
[TBL] [Abstract][Full Text] [Related]
15. The frequency of patients with dystrophin abnormalities in a limb-girdle patient population.
Arikawa E; Hoffman EP; Kaido M; Nonaka I; Sugita H; Arahata K
Neurology; 1991 Sep; 41(9):1491-6. PubMed ID: 1842672
[TBL] [Abstract][Full Text] [Related]
16. [A case of severe Becker muscular dystrophy diagnosed in early childhood--correlation between clinical severity and dystrophin testing].
Ishikawa Y; Ishikawa Y; Sumitani S; Minami R
No To Hattatsu; 1995 Jan; 27(1):53-7. PubMed ID: 7873253
[TBL] [Abstract][Full Text] [Related]
17. [Study of the gene deletions and the immunofluorescence of muscle in patients with DMD/BMD].
Dong YH; Lu PY; Wei C; Wang HB; Zhao BH
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 Nov; 21(4):453-6. PubMed ID: 21180173
[TBL] [Abstract][Full Text] [Related]
18. Malignant hyperthermia in a patient with Becker muscular dystrophy: dystrophin analysis and caffeine contracture study.
Ohkoshi N; Yoshizawa T; Mizusawa H; Shoji S; Toyama M; Iida K; Sugishita Y; Hamano K; Takagi A; Goto K
Neuromuscul Disord; 1995 Jan; 5(1):53-8. PubMed ID: 7719142
[TBL] [Abstract][Full Text] [Related]
19. Dystrophin immunohistochemistry in a symptomatic carrier of Becker muscular dystrophy.
Haginoya K; Yamamoto K; Iinuma K; Yanagisawa T; Ichinohasama Y; Shimmoto M; Suzuki Y; Tada K
J Neurol; 1991 Oct; 238(7):375-8. PubMed ID: 1683669
[TBL] [Abstract][Full Text] [Related]
20. Dystrophin-related protein in Becker muscular dystrophy.
Higuchi I; Niiyama T; Fukunaga H; Nakamura K; Nakagawa M; Osame M
Intern Med; 1994 Jun; 33(6):334-6. PubMed ID: 7919618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
